TickerTalks
Browse all tickers →
TickerTalks›$PIII
PIPIII

P3 Health Partners Inc.

$PIII·$32M·Medical - Care Facilities·Healthcare
$10.43-0.4%YTD+194.6%1Y+65.0%
Mentions · last 7 days
2026-07-08: 0 posts2026-07-09: 2 posts2026-07-10: 0 posts2026-07-11: 1 posts2026-07-12: 1 posts2026-07-13: 7 posts2026-07-14: 3 posts14+25%
Price updated 14h ago·X counts updated 14h ago
PIPIII
$PIIIP3 Health Partners Inc.
$10.43-0.38%14 posts+25%
AI analysisFundamentalsVoices on X
Loading…

AI verdict & sentimentAI analysisGenerated by AI from underlying data

Today's AI verdict on what's driving $PIII, plus how loud the X conversation is and which way it's leaning.

AI analysis

TickerTalks’ read on the fundamentals and what’s driving the move.

Comeback attemptAcceleratingAI verdict · as of 2026-07-14

The move is getting stronger, with heavier trading behind it.

P3 Health Partners has ripped 196% YTD on early operating-turn signals — $10.47 is +66% over 12 months, sitting 76% above the 200-day.

P3 Health Partners is a patient-centered, physician-led population health management company running clinics and wellness centers — the tape has responded to a fundamental turn from deep losses toward positive Q1 EPS.

  • Fundamentals show a real turn — Q1 revenue $386M up 3.5% YoY, operating margin swung to +2.1% (from -40% in Q4), EPS $0.37 versus deeply negative in prior quarters — a genuine operating inflection.
  • Balance sheet is stressed — negative book equity (D/E -0.43), ROIC -108% on trailing losses, and cash burn (FCF yield -223%) — the equity depends on continued operating improvement to avoid dilution.
  • Structural signals are supportive — float is tiny at 1.8M shares (extreme squeeze potential), 76% above the 200-day reflects the recent rip, and 30-day volume at 29% suggests low participation.

No aggregated X sentiment was available. The August 13 print is the release event — either the operating turn continues and the equity re-rates further, or Q1 was noise and the pressure resumes.

What to watch: August 13 Q2 earnings — sustained operating margin trajectory, cash burn, and any updated FY guide.

On the calendar: 2026-08-13 Q2 earnings

sentiment thin

Read the AI verdict + X sentiment for $PIII

  • One-line verdict on what's driving the move — fundamentals, momentum, both, or an event
  • Next dated catalyst when there is one (earnings, deal closing, activist clock)
  • X crowd read with bullish/bearish call + post volume
Free, forever. No credit card.

What it does

Plain-English summary of the business — what they sell and how they make money.

Value-based primary care company managing Medicare Advantage patient populations in the US.

Industry overviewAI analysisGenerated by AI from underlying data

Where Medical - Care Facilities sits in its cycle right now — and what that implies for $PIII.

Medical - Care Facilities · Healthcare

No material change from last week — hospital systems continue to rely on travel nursing and locum physician staffing to fill permanent workforce gaps that training pipelines cannot replenish at..

What this means for $PIII

Neutral — Value-based primary care company managing Medicare Advantage patient populations in the US; this business's revenue is largely decoupled from the travel nursing and locum physician staffing demand from hospital labor pressure.

Top industry ETF

$IHFiShares U.S. Healthcare Providers ETF
+18.7%YTD
+26.0%1Y

Fundamentals & catalyst

Profitability, valuation, and the next earnings event — at a glance, with rule-of-thumb signals.

Key ratios

P/E
-0.3How much investors are paying per dollar of profit the company actually earned in the last 12 months. Lower means the stock looks cheaper relative to earnings.~15–25 is typical for the S&P 500; high-growth names trade 30+; hyper-growth or speculative can be 100+ or negative.
ROIC
-108%What percentage return the business earns on every dollar of capital (equity + debt) deployed in operations. The cleanest measure of business quality.Above ~15% is high-quality; consistently above 25% suggests a real moat. Below the company's cost of capital is value-destroying.
Op margin
-15.2%Operating profit (after sales, marketing, R&D, and overhead but before interest and taxes) as a percentage of revenue. The clearest view of how well the underlying business is run.Mature business above 20% is healthy; software businesses can run 30%+; commodity / retail businesses operate in single digits.
FCF yield
-223%Free cash flow (operating cash flow minus capex) divided by the company's market cap. The cash-on-cash return you'd get owning the whole business at today's price.Above ~5% is attractive; below ~2% means you're paying up for growth. Capital-light businesses (software) run higher than capital-heavy ones (utilities).
P/S
0.0Same idea as P/E but per dollar of revenue. Useful for companies that aren't profitable yet, where P/E is meaningless.Under ~2 is cheap; software / SaaS often runs 8–15; well above 20 implies the market is pricing in very high future growth.
ROE
185%Net income as a percentage of shareholders' equity. Similar to ROIC but counts only the equity side.Above 20% is strong, but can be inflated by leverage — a heavily indebted company can show high ROE with weak underlying ROIC.
Gross margin
50.6%Revenue minus the direct cost of producing what was sold, as a percentage of revenue. The first read on whether the product is structurally profitable.Software / SaaS is typically 70%+; consumer goods 30–50%; commodity / hardware businesses can be under 20%.
D/E
-0.4Total debt divided by shareholders' equity. Measures how much the business runs on borrowed money versus owner capital.Under 1 is conservative; 1–2 is typical for mature businesses; over 2 is leveraged and more sensitive to interest rates.

Past earnings

QuarterReportedActualEstimateSurprise
Q1 2026May 14, 2026$-0.99$-4.85+79.6%
Q4 2025Mar 26, 2026$-23.02$-8.06-185.5%
Q3 2025Nov 14, 2025$-9.67$-5.29-82.7%
Q2 2025Aug 14, 2025$-6.23$-3.29-89.4%
Next earningsThu, Aug 13·consensus EPS $-1.90

Quarterly trend

QuarterRevenueYoYGrossOpEPSFCF
Q1 FY26$386.4M+3.5%7.6%2.1%$0.37$-27.5M
Q4 FY25$384.8M+3.8%100%-40.0%$-23.02$-25.5M
Q3 FY25$345.3M-4.7%-7.1%-12.8%$-9.67$-15.5M
Q2 FY25$355.8M-6.2%100%-9.6%$-6.23$-16.6M

Forward consensus

2-year forecast · up to 2 analysts
FYRevenueRangeEPSRangeAnalysts
FY26$1.5B$1.5B – $1.5B-$8.45-$8.58 – -$8.311
FY27$1.6B$1.6B – $1.7B-$3.00-$7.32 – $1.332

Setup & momentum

Volume, range, and moving-average position — the technical setup driving short-term moves.

Right now

Vol vs 30dToday's traded share volume divided by the average over the prior 30 trading days. ≥3× signals unusual interest; below 1× is quiet.0.2×Today's traded share volume divided by the average over the prior 30 trading days. ≥3× signals unusual interest; below 1× is quiet.
52w rangeWhere the latest close sits between the 52-week low (0%) and high (100%). Above 80% is extended; below 30% is basing or in a downtrend.58%Where the latest close sits between the 52-week low (0%) and high (100%). Above 80% is extended; below 30% is basing or in a downtrend.
vs 50d MALatest close vs the 50-day simple moving average. Positive = short-term trend is up.+4.4%Latest close vs the 50-day simple moving average. Positive = short-term trend is up.
vs 200d MALatest close vs the 200-day simple moving average. Positive = long-term trend is up.+75.4%Latest close vs the 200-day simple moving average. Positive = long-term trend is up.

Float & profile

FloatTiny float · 1.8M shFree-float shares — the slice of issued stock actually available to trade. Lower buckets squeeze harder on a catalyst.Traded today0.6% of floatToday's volume as a percent of the free float. Above 5% on a single day is unusually high turnover for the available share count.β1.625-year weekly beta vs the S&P 500. Above 1.5 means the stock typically moves more than the index; below 0.8 moves less.

Insider activity

Recent open-market buys and sells by officers and directors — flagged when multiple insiders cluster.

Recent transactions

No open-market buys or sells in the last 180 days.

+ 3 other (1 other · 1 conversion · 1 award) in window

See when $PIII insiders are putting their own money in

  • Real-time open-market buys and sells from Form 4 filings
  • Cluster-buy detection when multiple insiders pile in at once
  • 30 / 60 / 180-day windows so you can spot building conviction
Free, forever. No credit card.

SEC filings

Material 8-K, 13D, S-3, and 424B5 events from the last 180 days — the filings that actually move the price.

Recent material filings

8-KMaterial agreementJul 68-K — Item 1.01: Material agreement
AI summary

P3 Health Partners' subsidiary P3 Health Group, LLC amended its Repurchase Promissory Note with IHC Health Services on June 30, 2026 (Second Amendment), extending the note's maturity from a prior date to September 30, 2028 and adding PIK interest at 14% per annum from June 30, 2026 forward. The note originated in June 2019. Accruing PIK interest at 14% rather than paying cash preserves near-term liquidity for P3, but compounds the principal owed over the two-year extension — a sign of constrained cash, not strength.

8-KShareholder voteJun 108-K — Item 5.07: Shareholder vote
AI summary

P3 Health Partners held its 2026 Annual Meeting on June 9, 2026. Three Class II directors (Amir Bacchus, Mark Thierer, Lawrence Leisure) were elected for three-year terms; BDO USA, P.C. was ratified as independent auditor for fiscal year ending December 31, 2026; named executive officer compensation was approved on a non-binding advisory basis. Critically, stockholders approved under Nasdaq Rule 5635(d) the issuance of up to 3,341,130 shares of Class A common stock upon exercise of outstanding warrants held by VBC Growth SPV 5, LLC — a dilutive equity event tied to insider warrants. The warrant share issuance approval is the most material governance outcome, representing potential new dilution from a significant holder.

8-KListing / delisting noticeMay 268-K — Item 3.01: Listing / delisting notice
AI summary

P3 Health Partners Inc. received a Nasdaq delisting notice (previously disclosed November 28, 2025) for failure to satisfy minimum bid price or stockholders' equity requirements. The company has a plan to regain compliance within the Nasdaq-specified timeframe. This filing updates the status of the ongoing delisting proceeding; failure to regain compliance would result in P3 Health Partners shares being delisted from Nasdaq.

8-KListing / delisting noticeMay 158-K — Item 3.01: Listing / delisting notice · Item 8.01: Other event
AI summary

P3 Health Partners Inc. provided an update on its Nasdaq listing compliance proceeding in conjunction with other events (Item 8.01); this supplements the November 28, 2025 initial delisting notice. P3 is working toward satisfying Nasdaq listing requirements within the allowed cure period. Continued non-compliance or failure to gain an extension would result in delisting from Nasdaq for this value-based care company.

8-KMaterial agreementApr 288-K — Item 1.01: Material agreement · Item 3.02: Unregistered equity sale · Item 5.03: Charter amendment
AI summary

P3 Health Partners (PIII) entered a Debt Exchange Agreement on April 27, 2026, with affiliates of a Chicago-based entity, exchanging existing debt for equity or new securities to bring the company into compliance with Nasdaq Listing Rule 5550(b)(1), which requires a minimum of $2.5 million in stockholders' equity. The transaction involves issuance of unregistered equity (Item 3.02) and an amendment to organizational documents (Item 5.03). This is a balance-sheet-repair transaction to avoid delisting.

8-KMaterial agreementMar 258-K — Item 1.01: Material agreement
8-KMaterial agreementFeb 178-K — Item 1.01: Material agreement
+ 8 other (2 earnings 8-Ks · 2 proxys · 1 10-Q · 1 PRE 14A) in window

Recent news

Latest headlines from major outlets, sourced and timestamped — context for whatever just moved.

Trump Rattled Markets Again and These 3 Forgotten Stocks Under $30 Were the Unlikely Winners247wallst.com·58d agoP3 Health Partners Announces First Quarter 2026 Resultsbusinesswire.com·62d agoP3 Health Partners Schedules First Quarter 2026 Earnings Release and Conference Callbusinesswire.com·90d ago

More in Medical - Care Facilities

Peers in the same group — one click to compare setups, fundamentals, and chatter.

$NAKA$CMPS$AMN$DVA
Voices on X · last 7 days

No standout posts about $PIII on X in the last 7 days.

TickerTalks is a research tool, not financial advice. We surface social-attention data; we do not make stock recommendations. Past attention is not predictive of future price movements.

PrivacyTermsSupport